The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Tumor-specific expression of αvβ3 integrin promotes spontaneous metastasis of breast cancer to bone
Open accessAbstract
Introduction: Studies in xenograft models and experimental models of metastasis have implicated several β3 integrin-expressing cell populations, including endothelium, platelets and osteoclasts, in breast tumor progression. Since orthotopic human xenograft models of breast cancer are poorly metastatic to bone and experimental models bypass the formation of a primary tumor, however, the precise contribution of tumor-specific αvβ3 to the spontaneous metastasis of breast tumors from the mammary gland to bone remains unclear. Methods: We used a syngeneic orthotopic model of spontaneous breast cancer metastasis to test whether exogenous expression of αvβ3 in a mammary carcinoma line (66cl4) that metastasizes to the lung, but not to bone, was sufficient to promote its spontaneous metastasis to bone from the mammary gland. The tumor burden in the spine and the lung following inoculation of αvβ3-expressing 66cl4 (66cl4beta3) tumor cells or control 66cl4pBabe into the mammary gland was analyzed by real-time quantitative PCR. The ability of these cells to grow and form osteolytic lesions in bone was determined by histology and tartrate-resistant acid phosphatase staining of bone sections following intratibial injection of tumor cells. The adhesive, migratory and invasive properties of 66cl4pBabe and 66cl4beta3 cells were evaluated in standard in vitro assays. Results: The 66cl4beta3 tumors showed a 20-fold increase in metastatic burden in the spine compared with 66cl4pBabe. A similar trend in lung metastasis was observed. αvβ3 did not increase the proliferation of 66cl4 cells in vitro or in the mammary gland in vivo. Similarly, αvβ3 is not required for the proliferation of 66cl4 cells in bone as both 66cl4pBabe and 66cl4beta3 proliferated to the same extent when injected directly into the tibia. 66cl4beta3 tumor growth in the tibia, however, increased osteoclast recruitment and bone resorption compared with 66cl4 tumors. Moreover, αvβ3 increased 66cl4 tumor cell adhesion and αvβ3-dependent haptotactic migration towards bone matrix proteins, as well as their chemotactic response to bone-derived soluble factors in vitro. Conclusion: These results demonstrate for the first time that tumor-specific αvβ3 contributes to spontaneous metastasis of breast tumors to bone and suggest a critical role for this receptor in mediating chemotactic and haptotactic migration towards bone factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Giancotti, F. G., & Ruoslahti, E. (1999) · Science · doi:10.1126/science.285.5430.1028 · Cited by 3,869
Requirement of Vascular Integrin α v β 3 for Angiogenesis
Brooks, P. C., Clark, R. A. F., & Cheresh, D. A. (1994) · Science · doi:10.1126/science.7512751 · Cited by 3,020
Aslakson, C. J., & Miller, F. R. (1992) · PubMed · Cited by 1,234
The clinical course of bone metastases from breast cancer
Coleman, R., & Rubens, R. (1987) · British Journal of Cancer · doi:10.1038/bjc.1987.13 · Cited by 1,084
Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin.
Brooks, P. C., Strömblad, S., Klemke, R., Visscher, D., Sarkar, F. H., & Cheresh, D. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118227 · Cited by 828
Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins
Reynolds, L. E., Wyder, L., Lively, J. C., Taverna, D., Robinson, S. D., Huang, X., Sheppard, D., Hynes, R. O., & Hodivala-Dilke, K. M. (2002) · Nature Medicine · doi:10.1038/nm0102-27 · Cited by 613
Integrin activation controls metastasis in human breast cancer
Felding-Habermann, B., O'Toole, T. E., Smith, J. W., Fransvea, E., Ruggeri, Z. M., Ginsberg, M. H., Hughes, P. E., Pampori, N., Shattil, S. J., Saven, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1853 · Cited by 577
Schneller, M. (1997) · The EMBO Journal · doi:10.1093/emboj/16.18.5600 · Cited by 492
Boucharaba, A., Serre, C.-M., Grès, S., Saulnier-Blache, J. S., Bordet, J.-C., Guglielmi, J., Clézardin, P., & Peyruchaud, O. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422123 · Cited by 462
A novel orthotopic model of breast cancer metastasis to bone
Lelekakis, M., Moseley, J. M., Martin, T. J., Hards, D., Williams, E., Ho, P., Lowen, D., Javni, J., Miller, F. R., Slavin, J., et al. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006689719505 · Cited by 427
Self-citationDeryugina, E. I., Ratnikov, B., Monosov, E., Postnova, T. I., DiScipio, R., Smith, J. W., & Strongin, A. Y. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5118 · Cited by 387
Rolli, M., Fransvea, E., Pilch, J., Saven, A., & Felding-Habermann, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633689100 · Cited by 332
Morgenstern, J. P., & Land, H. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.4.1068 · Cited by 306
Clinical course and prognostic factors following bone recurrence from breast cancer
Coleman, R., Smith, P., & Rubens, R. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.52 · Cited by 293
Borges, E., Jan, Y., & Ruoslahti, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007040200 · Cited by 293
Adhesion events in angiogenesis
Eliceiri, B. P., & Cheresh, D. A. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00252-0 · Cited by 287
Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer.
Gasparini, G., Brooks, P. C., Biganzoli, E. M., Vermeulen, P. B., Bonoldi, E., Dirix, L. Y., Ranieri, G., Miceli, R., & Cheresh, D. A. (1998) · PubMed · Cited by 280
Mechanisms of osteolytic bone metastases in breast carcinoma
K�k�nen, S.-M., & Mundy, G. R. (2003) · Cancer · doi:10.1002/cncr.11132 · Cited by 269
Silletti, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011343298 · Cited by 262
The Role of αvβ3 in Prostate Cancer Progression
Cooper, C. R., Chay, C. H., & Pienta, K. J. (2002) · Neoplasia · doi:10.1038/sj.neo.7900224 · Cited by 238
Platelet and osteoclast β 3 integrins are critical for bone metastasis
Bakewell, S. J., Nestor, P., Prasad, S., Tomasson, M. H., Dowland, N., Mehrotra, M., Scarborough, R., Kanter, J., Abe, K., Phillips, D., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2234372100 · Cited by 233
Eckhardt, B. L., Parker, B. S., van Laar, R. K., Restall, C. M., Natoli, A. L., Tavaria, M. D., Stanley, K. L., Sloan, E. K., Moseley, J. M., & Anderson, R. L. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.1.3.1 · Cited by 224
Self-citationIntegrin αvβ3 expression confers on tumor cells a greater propensity to metastasize to bone
Pecheur, I., Peyruchaud, O., Serre, C., Guglielmi, J., Voland, C., Bourre, F., Margue, C., Cohen‐Solal, M., Buffet, A., Kieffer, N., et al. (2002) · The FASEB Journal · doi:10.1096/fj.01-0911fje · Cited by 223
Doerr, M. E., & Jones, J. I. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.5.2443 · Cited by 216
Deryugina, E. I., Ratnikov, B. I., Postnova, T. I., Rozanov, D. V., & Strongin, A. Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110269200 · Cited by 212
Integrin αvβ3 Expression by Bone-residing Breast Cancer Metastases
Liapis, H., Flath, A., & Kitazawa, S. (1996) · Diagnostic Molecular Pathology · doi:10.1097/00019606-199606000-00008 · Cited by 186
Max, R., Gerritsen, R. R. C. M., Nooijen, P. T. G. A., Goodman, S. L., Sutter, A., Keilholz, U., Ruiter, D. J., & De Waal, R. M. W. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970502)71:3<320::aid-ijc2>3.0.co;2-# · Cited by 175
Pignatelli, M., Cardillo, M. R., Hanby, A., & Stamp, G. W. H. (1992) · Human Pathology · doi:10.1016/0046-8177(92)90034-z · Cited by 168
The synergistic activity of αvβ3 integrin and pdgf receptor increases cell migration
Woodard, A. S., García-Cardeña, G., Leong, M., Madri, J. A., Sessa, W. C., & Languino, L. R. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.4.469 · Cited by 165
Sung, V., Stubbs, J. T., Fisher, L. W., Aaron, A. D., & Thompson, E. W. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199809)176:3<482::aid-jcp5>3.0.co;2-k · Cited by 146
Takayama, S., Ishii, S., Ikeda, T., Masamura, S., Doi, M., & Kitajima, M. (2005) · PubMed · Cited by 134
Involvement of tumor cell integrin αvβ3 in hematogenous metastasis of human melanoma cells
Felding‐Habermann, B., Fransvea, E., O’Toole, T. E., Manzuk, L. K., Faha, B., & Hensler, M. E. (2002) · Clinical & Experimental Metastasis · doi:10.1023/a:1016377114119 · Cited by 133
Tester, A. M., Sanchavanakit, N., Anderson, R. L., & Thompson, E. W. (2000) · Clinical & Experimental Metastasis · doi:10.1023/a:1011953118186 · Cited by 124
Self-citationA small molecule antagonist of the α v β3 integrin suppresses MDA-MB-435 skeletal metastasis
Harms, J. F., Welch, D. R., Samant, R. S., Shevde, L. A., Miele, M. E., Babu, G. R., Goldberg, S. F., Gilman, V. R., Sosnowski, D. M., Campo, D. A., et al. (2004) · Clinical & Experimental Metastasis · doi:10.1023/b:clin.0000024763.69809.64 · Cited by 109
Zhou, Q., Sherwin, R. P., Parrish, C., Richters, V., Groshen, S. G., Tsao-Wei, D. D., & Markland, F. S. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006457903545 · Cited by 108
Steitz, J., Br�ck, J., Steinbrink, K., Enk, A., Knop, J. X. F. R., & Tüting, T. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000401)86:1<15::aid-ijc3>3.0.co;2-b · Cited by 106
Increased primary tumor growth in mice null for β3- or β3/β5-integrins or selectins
Taverna, D., Moher, H., Crowley, D. G., Borsig, L., Varki, A. P., & Hynes, R. O. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307289101 · Cited by 101
Pereira, J. J., Meyer, T., Docherty, S. E., Reid, H. H., Marshall, J. F., Thompson, E. W., Rossjohn, J., & Price, J. T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3056 · Cited by 96
Pouliot, N., Saunders, N. A., & Kaur, P. (2002) · Experimental Dermatology · doi:10.1034/j.1600-0625.2002.110501.x · Cited by 92
Self-citationFurger, K. A., Allan, A. L., Wilson, S. M., Hota, C., Vantyghem, S. A., Postenka, C. O., Al‐Katib, W., Chambers, A. F., & Tuck, A. B. (2003) · PubMed · Cited by 92
Baciu, P. C., Suleiman, E. A., Deryugina, E. I., & Strongin, A. Y. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00387-2 · Cited by 75
Nemeth, J. A., Cher, M. L., Zhao, Z., Mullins, C. M., Bhagat, S., & Trikha, M. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1025461507027 · Cited by 74
Genes involved in breast cancer metastasis to bone
Sloan, E. K., & Anderson, R. L. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8524-5 · Cited by 74
Self-citationTucker, G. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00175-3 · Cited by 73
Role of stromal-derived cytokines and growth factors in bone metastasis
Roodman, G. D. (2003) · Cancer · doi:10.1002/cncr.11148 · Cited by 71
Hewitt, R. E., Powe, D. G., Morrell, K., Balley, E., LEACH, I. H., Ellis, I. O., & Turner, D. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.37 · Cited by 69
Anti-metastatic properties of RGD-peptidomimetic agents S137 and S247
Shannon, K. E., Keene, J. L., Settle, S. L., Duffin, T. D., Nickols, M. A., Westlin, M. M., Schroeter, S., Ruminski, P., & Griggs, D. W. (2004) · Clinical & Experimental Metastasis · doi:10.1023/b:clin.0000024764.93092.5f · Cited by 68
Integrin β3 Overexpression Suppresses Tumor Growth in a Human Model of Gliomagenesis
Kanamori, M., VandenBerg, S., Bergers, G., Berger, M. S., & Pieper, R. O. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3354 · Cited by 58
Zutter, M. M., Sun, H. Y., & Santoro, S. A. (1998) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1018798907544 · Cited by 55
Varner, J. A., Nakada, M. T., Jordan, R. E., & Coller, B. S. (1999) · Angiogenesis · doi:10.1023/a:1009019223744 · Cited by 44
Gomes, N., Vassy, J., Lebos, C., et al. (2004) · Clinical & Experimental Metastasis · doi:10.1007/s10585-004-3756-4 · Cited by 35
Deryugina, E. I., Ratnikov, B. I., & Strongin, A. Y. (2003) · International Journal of Cancer · doi:10.1002/ijc.10977 · Cited by 30
Development of skeletal metastases.
Kitazawa, S., & Maeda, S. (1995) · PubMed · Cited by 28
Cited by
Integrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2748 · Cited by 3,736
Tian, Y., Li, S., Song, J., Ji, T., Zhu, M., Anderson, G. J., Wei, J., & Nie, G. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.083 · Cited by 1,801
Targeting integrin pathways: mechanisms and advances in therapy
Pang, X., He, X., Qiu, Z., Zhang, H., Xie, R., Liu, Z., Gu, Y., Zhao, N., Xiang, Q., & Cui, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01259-6 · Cited by 1,275
The sympathetic nervous system induces a metastatic switch in primary breast cancer
Sloan, E. K., Priceman, S. J., Cox, B. F., Yu, S., Pimentel, M. A., Tangkanangnukul, V., Arevalo, J. M. G., Morizono, K., Karanikolas, B. D. W., Wu, L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0522 · Cited by 930
Self-citationThe dormant cancer cell life cycle
Phan, T. G., & Croucher, P. I. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0263-0 · Cited by 576
Metadata
- Authors
- Sloan, E. K., Pouliot, N., Stanley, K. L., Chia, J., Moseley, J. M., Hards, D. K., & Anderson, R. L.
- Venue
- Breast Cancer Research
- Published
- 2006-04-11
- Volume
- 8
- Issue
- 2
- Pages
- R20-R20
- ISSN
- 1465-5411 (ISSN-L)
- 1465-542X
- OpenAlex
- W1734622341
- Cited by
- 275
- References
- 54
- FWCI
- 7.04
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.